KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Goodwill (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 17 years of Goodwill data on record, last reported at $1.1 billion in Q3 2025.

  • For Q3 2025, Goodwill changed 0.0% year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $1.1 billion, changed 0.0%, while the annual FY2024 figure was $1.1 billion, 0.0% changed from the prior year.
  • Goodwill reached $1.1 billion in Q3 2025 per VRTX's latest filing, roughly flat from $1.1 billion in the prior quarter.
  • Across five years, Goodwill topped out at $1.1 billion in Q4 2022 and bottomed at $1.0 billion in Q1 2021.
  • Average Goodwill over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
  • Peak YoY movement for Goodwill: changed 0.0% in 2021, then rose 8.56% in 2022.
  • A 5-year view of Goodwill shows it stood at $1.0 billion in 2021, then increased by 8.56% to $1.1 billion in 2022, then changed by 0.0% to $1.1 billion in 2023, then changed by 0.0% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $1.1 billion in Q3 2025, $1.1 billion in Q2 2025, and $1.1 billion in Q4 2024.